History
Alcohol-related liver disease has become established as a term that groups, in stages, "liver damage caused by alcohol." It has long been observed that cirrhosis and jaundice are linked to heavy drinking, and as medicine advanced, the progression was described in which the changes that alcohol causes in the liver can lead from "fat accumulation → inflammation (hepatitis) → scarring (fibrosis) → cirrhosis." As characteristic findings became known on microscopic examination of the liver, such as fat filling the liver cells, inflammatory cells gathering, and specific protein clumps (Mallory bodies) being seen, it began to be described as a single disease spectrum.
The terminology has also changed. In the past, the expression "alcoholic" was widely used, but as awareness grew that it could stigmatize the person rather than describe the disease itself, expressions such as "alcohol-related liver disease" or "alcohol-associated liver disease" gradually spread. Recent studies suggest that this change in terminology is not merely a matter of language but can be a practical tool that helps patients participate better in the treatment process (especially treatment of drinking problems).
Another historical change is the shift in perspective from "treating only the liver is enough" to "the drinking problem and the liver disease must be treated together." It is common for liver values to improve briefly, but because the damage quickly returns if a person drinks again, it has been emphasized that the success or failure of liver treatment is ultimately directly tied to maintaining abstinence. Recent studies report that a care model integrating specialist liver care and addiction treatment is important in reducing the risk of readmission and death.
Causes
The cause of alcohol-related liver disease is not simply "having drunk alcohol" but "having been repeatedly exposed over a long period to amounts of alcohol that the liver has difficulty handling." Alcohol is absorbed from the digestive tract and enters the liver, and the liver produces toxic substances and oxidative stress in the process of detoxifying it. When this process is repeated, liver cells accumulate fat, inflammation develops, and scarring increases. The biggest factors determining risk are the amount consumed and the duration. The higher the average daily intake, the more frequent the binge drinking, and the more continuously a person drinks without days off, the greater the risk.
That said, not everyone develops the disease equally. The reason only some heavy drinkers progress to severe hepatitis or cirrhosis is that constitution and environment act together. Liver damage can be more severe if nutritional status is poor, if there is protein or vitamin deficiency, or if metabolic abnormalities such as obesity and diabetes coexist. If hepatitis virus infection is also present, the damage can progress much faster, so alcohol intake must be restricted more strictly.
Recent studies emphasize that it is not a problem of alcohol alone, but that obesity, smoking, viral hepatitis, socioeconomic factors, and others are intertwined and increase the burden of alcohol-related liver disease. In other words, the cause of alcohol-related liver disease should be understood not as the single factor of alcohol but as the result of complex environmental and individual factors overlapping over a long period.
Genetic Epidemiology
In alcohol-related liver disease, heredity is involved in two directions: "a tendency to drink more" and "a sensitivity whereby the liver is more easily damaged by the same amount of alcohol." Family history and twin studies have shown a tendency for drinking problems and the risk of cirrhosis to be elevated together within families. However, having a hereditary predisposition does not mean that liver disease will necessarily develop; the amount of drinking and the living environment play a much larger role.
There are individual differences in the enzymes that break down alcohol (alcohol dehydrogenase, aldehyde dehydrogenase, and others). Some people have a strong reaction in which their face turns red and their heart pounds when they drink, and such constitutional differences change the pattern of exposure to alcohol and its metabolites and can, over the long term, influence drinking habits and disease risk. Recent studies suggest that not only heredity but also epigenetics, individual differences in inflammatory responses, and differences in the composition of the gut microbiota can determine the rate of disease progression.
Summarizing genetic epidemiology from a layperson's point of view, one can say that "heredity may tilt the playing field, but what ultimately determines the outcome of the game is the amount and duration of drinking, maintaining abstinence, and management of comorbidities."
General Epidemiology
Alcohol-related liver disease has become a major cause of cirrhosis and liver-related death in many regions, including Western countries. In societies where alcohol consumption is increasing, alcohol-related liver disease is increasing, and reports continue that the increase is pronounced among younger age groups and women. Recent studies present analyses showing that deaths related to alcohol-related liver disease have been on an increasing trend over a long period, and that the rate of increase has become even steeper in the past few years.
Rather than being discovered as "cirrhosis" all at once, alcohol-related liver disease often begins with asymptomatic fatty liver in the early stage. In actual clinical settings, however, it is not uncommon for it to be discovered for the first time through complications such as ascites, variceal bleeding, and changes in consciousness after "going unnoticed because there were no symptoms." It is also important that risk differs between groups. It has long been known that women are more vulnerable to liver damage even when drinking the same amount.
The key to understanding the epidemiology is not only the simple formula that "when more people drink heavily, liver disease also increases," but also that structural factors such as social stress, mental health, drinking culture, and access to medical care jointly determine prevalence and mortality.
Pathogenesis
The pathogenesis of alcohol-related liver disease can be summarized broadly as "the toxicity of alcohol metabolism," "inflammatory and immune responses," and "the gut-liver axis (the connection between the intestinal environment and the liver)." First, as alcohol is metabolized in the liver, it produces toxic substances such as acetaldehyde. These substances bind to proteins, impair cell function, and increase oxidative stress. In addition, the process of alcohol metabolism changes the oxidation-reduction balance within cells, so that fat is more readily produced in the liver and is not burned off easily.
Second, when oxidative stress and toxic metabolites accumulate, liver cells are damaged and inflammatory substances increase. The immune cells of the liver are activated, and as inflammatory cytokines increase, hepatitis is induced. When this inflammation is repeated, the stellate cells of the liver are activated, collagen accumulates, and fibrosis progresses. Third, when the intestinal barrier weakens and components of intestinal bacteria enter the liver more easily through the portal vein, the inflammatory response in the liver becomes greater. This is the core of the gut-liver axis.
Recent studies suggest that changes in the gut microbiota, changes in bile acids, and failure of immune response regulation can affect the severity of alcoholic hepatitis. There is a growing tendency to understand alcohol-related liver disease not as a problem of the liver alone but as a multiorgan disease in which systemic metabolic, immune, and neural signals are intertwined.
Symptoms
Alcohol-related liver disease often causes almost no symptoms in the early stage. At the fatty liver stage, there may be only fatigue or no symptoms at all. It is therefore common for it to be discovered incidentally when liver values come out high on health checkup blood tests or when an abdominal ultrasound is performed for another reason. If it progresses and alcoholic hepatitis develops, the symptoms may become distinct. Loss of appetite, nausea, weight loss, and generalized fatigue become severe, and jaundice, in which the skin and eyes turn yellow, may appear.
When it progresses to cirrhosis, symptoms arise from "decreased liver function" and "increased portal pressure." The abdomen swells and the legs become swollen, and easy bruising or nosebleeds and gum bleeding may increase. Sudden vomiting of blood or black stools may occur, as in esophageal variceal bleeding, and confusion and changes in the sleep-wake rhythm may appear due to hepatic encephalopathy.
The important point is that by the time symptoms appear, the damage has often already progressed considerably. Therefore, even when there are no symptoms, if a person drinks heavily and has risk factors, it is safer to begin stage assessment through testing and intervention for abstinence.
Signs
Signs are the objective findings confirmed on examination and testing. In early alcohol-related liver disease, there may be no noticeable physical signs. As it progresses, however, the typical signs of chronic liver disease gradually appear. Elevated liver enzymes are common on blood tests, and especially in alcoholic hepatitis, a pattern is often mentioned in which aspartate aminotransferase is higher than alanine aminotransferase (a high ratio) and the levels rise within a certain range rather than soaring to very high absolute values.
On examination, the liver may be enlarged or tender, and in advanced cirrhosis, jaundice, ascites, leg swelling, spider angiomas, palmar erythema, muscle loss, splenomegaly, and other findings may be observed. Imaging may show findings of fatty liver, an irregular liver surface, splenomegaly, ascites, and others. However, whether the imaging findings of fatty liver are "due to alcohol" cannot be confirmed by imaging alone; the history (drinking history) and exclusion of other causes are also needed.
Recent studies emphasize that malnutrition and muscle loss have a major impact on prognosis in patients with alcohol-related liver disease. Accordingly, there is a growing emphasis that, when looking at signs, it is important to evaluate not only liver values but also weight change, muscle strength, and nutritional status together.
Screening
The purpose of screening is to identify early "those among heavy drinkers in whom scarring of the liver is progressing." Because alcohol-related liver disease is often asymptomatic in the early stage and its severity is difficult to gauge accurately from liver values alone, stepwise screening focused on high-risk groups is important. The first step is confirming the drinking history. The starting point of screening is to ask specifically how often, how much at a time, and for how many years a person has drunk, and also to check for binge drinking and experiences of attempting and failing to quit.
The second step is basic blood tests and liver function assessment. Liver enzymes, platelets, bilirubin, albumin, coagulation values, and others are considered together to assess the likelihood of liver damage and reduced function. The third step is noninvasive fibrosis assessment. Scores that estimate how stiff the liver has become (fibrosis) or liver elastography are used to separate low-risk and high-risk groups. Recent studies propose expanding such noninvasive screening in primary care and the community to reduce "cirrhosis first discovered in the emergency department."
Recent studies point out that some noninvasive tests and markers may be less accurate during periods of active drinking. It is therefore practical not to end screening with a single test but to reassess after a certain period together with an intervention for abstinence.
Diagnosis
Diagnosis is a process of determining both "whether alcohol is the main cause" and "what stage it is currently at." The stages can be broadly understood as fatty liver, alcoholic hepatitis, and fibrosis/cirrhosis. The most important diagnostic tool is the history. The amount and pattern of drinking are confirmed specifically, and whether alcohol use disorder (loss of control, withdrawal, social problems, and others) is present is evaluated. Next, other causes of liver disease are excluded. Because viral hepatitis, medications, autoimmune liver disease, fatty liver due to metabolic abnormalities, and others may coexist, the necessary tests are performed.
Blood tests reflect liver cell damage, cholestasis, the liver's synthetic function, and the degree of inflammation. When alcoholic hepatitis is suspected, clinical criteria and prognostic scores are used to assess severity and help with treatment decisions. Imaging helps confirm findings of fatty liver and cirrhosis and clues of increased portal pressure. Liver elastography estimates the degree of fibrosis and can be used for follow-up and referral decisions.
Recent studies emphasize that in the care of alcohol-related liver disease, treatment outcomes improve when "diagnosis of the liver disease" and "diagnosis of alcohol use disorder" are made together. In other words, if only the liver is diagnosed and the drinking problem is not addressed, the risk of relapse and worsening is very high.
Treatment
The key to treatment is abstinence from alcohol. Abstinence is the most powerful intervention that changes the prognosis at every stage. At the fatty liver stage, abstinence alone can reduce liver fat and allow recovery. Even at the hepatitis or cirrhosis stage, abstinence is decisive in lowering the risk of complications and death. Abstinence is difficult to achieve through "willpower" alone. If alcohol use disorder is present, treatment including counseling, behavioral therapy, drug therapy, and family and social support is needed. Nutritional therapy is also important. Malnutrition and muscle loss are common in patients with alcohol-related liver disease, and sufficient calories and protein and vitamin supplementation may be needed.
If alcoholic hepatitis is severe, inpatient treatment is needed, and in some patients corticosteroid treatment can improve short-term survival. However, it must be chosen carefully, taking into account the risk of infection, the risk of bleeding, and other factors. If it progresses to cirrhosis and complications develop, standard cirrhosis treatment such as control of ascites, prevention and treatment of variceal bleeding, and treatment of hepatic encephalopathy is provided at the same time. In end-stage liver failure, liver transplantation may be the only definitive treatment.
Recent studies emphasize that integrated care, in which specialist liver care and addiction treatment are provided by a single team, is effective. Liver transplantation has good survival rates in selected patients, but maintaining abstinence before and after transplantation and assessing the risk of relapse are very important.
Prognosis
The prognosis depends greatly on the stage and on whether a person abstains. The fatty liver stage has a relatively good prognosis, and with abstinence the likelihood of recovery is high. However, if drinking continues, the likelihood of progressing to alcoholic hepatitis or fibrosis/cirrhosis increases. Alcoholic hepatitis is a disease that can worsen rapidly and carries a high risk of short-term death. High-risk patients must be identified through severity assessment, and complications such as infection and bleeding must be managed actively.
When it progresses to cirrhosis, the prognosis is divided into "compensated" and "decompensated." Compensated cirrhosis, in which there are not yet complications, can remain relatively stable if abstinence is maintained, but when decompensating complications such as ascites, variceal bleeding, and hepatic encephalopathy develop, the risk of hospitalization and death increases greatly. Recent studies report that deaths related to alcohol-related liver disease are on an increasing trend and that the increase may be pronounced among younger age groups and women.
If one most important factor that changes the prognosis were to be named, it would be maintaining abstinence. If abstinence is maintained, liver function may recover to the point that transplantation can be avoided in some cases, and even with cirrhosis the rate at which complications develop can be slowed. In assessing prognosis, it is important not to think "just quitting alcohol is enough" but to look at weight, blood glucose, nutrition, mental health, and social support together.
Prevention
The key to prevention is "not starting hazardous drinking, or cutting down and quitting as early as possible." Because the cause of alcohol-related liver disease is relatively clear, lifestyle interventions are highly effective. The more specific the practical strategies, the better. It helps to set and record the number of drinking days per week and the amount per occasion, avoid binge drinking, reduce drinking on an empty stomach, and secure alcohol-free days. However, if loss of control has already occurred repeatedly, "abstinence" is often a more realistic goal than "moderation."
Prevention includes managing accompanying risk factors. If obesity, diabetes, or hyperlipidemia is present, liver damage can be greater even with the same amount of drinking, so improving weight and metabolic markers increases the preventive effect. If a hepatitis virus is present, alcohol can accelerate the damage, so drinking must be strictly limited along with treatment. Mental health and social factors are also important. Stress, depression, anxiety, and sleep disorders worsen drinking and become obstacles to maintaining abstinence.
Finally, if fatty liver or abnormal liver values are found at a health checkup, rather than passing it off with "it's fine for now," reassessing the drinking history and checking the risk of fibrosis is important for secondary prevention (preventing worsening). Recent studies suggest that integrated prevention strategies that also address factors such as stress, depression, and anxiety are effective.